Heghine Khachatryan: How Well Do We Recognize Anti-PF4 Disorders?
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared Shinya Goto‘s post on LinkedIn:
“An outstanding and highly relevant review on platelet-activating anti-PF4 disorders.
For practicing clinicians, these immune-mediated thrombotic syndromes are no longer rare academic entities.
HIT, autoimmune HIT, spontaneous HIT, VITT, and VITT-like disorders are increasingly recognized across diverse clinical settings, making early suspicion, timely laboratory diagnosis, and prompt initiation of appropriate therapy essential for improving patient outcomes.
This review provides an excellent synthesis of current concepts in the pathophysiology, diagnosis, and management of anti-PF4 disorders and will undoubtedly become an important reference for physicians involved in thrombosis, hemostasis, intensive care, hematology, and vascular medicine.
Congratulations to the authors on this outstanding contribution to the field.”
Shinya Goto, Director and Chairman in Metabolic Disease Research Center, shared a post on LinkedIn about a recent article by Theodore E. Warkentin et al., published in NEJM, adding:
“Very good review regarding Platelet-Activating Anti–Platelet Factor 4 Disorders including HIT!”
Title: Very good review regarding Platelet-Activating Anti–Platelet Factor 4 Disorders including HIT!
Authors: Theodore E. Warkentin, Andreas Greinacher
Other posts featuring Heghine Khachatryan on Hemostasis Today.
-
Oct 17, 2026, 17:27John Strouse: Building Standards for Whole-Person Sickle Cell Care Through Collaboration
-
Oct 17, 2026, 17:20Jean-Jacques Kiladjian: Exploring the Future of Polycythemia Vera Treatment at MPN Horizons 2026
-
Oct 17, 2026, 17:10Habib Bennaceur: Strengthening Collaboration in Haemophilia, Sickle Cell Disease and Thalassaemia in India
-
Oct 17, 2026, 16:58Danny Hsu: Building Connections at the AUSNBled Collaborative Dinner in Auckland
-
Oct 17, 2026, 16:48Kalyan Roy: Enhancing Patient Experience Through Learning and Collaboration
-
Oct 17, 2026, 16:43Wilfried Dinh: Antiplatelet Therapy in 2026: Duration is Becoming a Dynamic Decision
-
Oct 17, 2026, 16:37Ian Setchfield: Dr. Evans Presents on Safe Anticoagulation Prescribing at East Kent Hospitals
-
Oct 17, 2026, 16:33Lewis Thomas: Connecting Through Shared Experiences at ASCAT 2026
-
Oct 17, 2026, 16:29Nilesh Jethwa: Yasmin Adverse Event Reports Exceed 23,000 Over Two-Year Period